Holen Sie sich die Stockscreener-App
16.07
0.56%
0.09
Handel nachbörslich:
16.07
Schlusskurs vom Vortag:
$15.98
Offen:
$15.93
24-Stunden-Volumen:
732.90K
Relative Volume:
0.59
Marktkapitalisierung:
$1.40B
Einnahmen:
$12.59M
Nettoeinkommen (Verlust:
$-212.39M
KGV:
-5.2086
EPS:
-3.0853
Netto-Cashflow:
$-185.92M
1W Leistung:
+2.42%
1M Leistung:
+37.23%
6M Leistung:
+82.82%
1J Leistung:
+40.10%
1-Tages-Spanne:
$15.64
$16.43
1-Wochen-Bereich:
$15.36
$17.20
52-Wochen-Spanne:
$5.1501
$17.32
Immunome Inc Stock (IMNM) Company Profile
Firmenname
Immunome Inc
Sektor
Branche
Telefon
610-321-3700
Adresse
18702 N. CREEK PARKWAY, BOTHELL
Vergleichen Sie IMNM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
16.07 | 1.39B | 12.59M | -212.39M | -185.92M | -3.0853 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Immunome Inc Stock (IMNM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-22 | Eingeleitet | Goldman | Buy |
| 2025-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2025-04-02 | Eingeleitet | Lake Street | Buy |
| 2024-11-08 | Eingeleitet | Stephens | Overweight |
| 2024-05-31 | Eingeleitet | Piper Sandler | Overweight |
| 2024-04-30 | Eingeleitet | JP Morgan | Overweight |
| 2024-04-15 | Eingeleitet | Guggenheim | Buy |
| 2024-01-29 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-19 | Eingeleitet | Wedbush | Outperform |
| 2021-10-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Immunome Inc Aktie (IMNM) Neueste Nachrichten
Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference - The AI Journal
Is Immunome Inc. stock bottoming outJuly 2025 Price Swings & Fast Entry Momentum Trade Alerts - newser.com
Using economic indicators to assess Immunome Inc. potentialMarket Performance Summary & Fast Entry High Yield Stock Tips - newser.com
Will Immunome Inc. stock reach Wall Street targetsStock Surge & Safe Entry Momentum Tips - newser.com
Historical volatility pattern of Immunome Inc. visualized2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - newser.com
What technical signals suggest for Immunome Inc. stock2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com
Evaluating Immunome Inc. with trendline analysisJuly 2025 Big Picture & Reliable Entry Point Trade Alerts - newser.com
Is Immunome Inc. stock a safe haven assetFed Meeting & Fast Gain Stock Trading Tips - newser.com
Immunome Bets Big On Cancer Drugs As Shares Outpace The Market - Finimize
How Immunome Inc. stock benefits from tech adoptionWeekly Investment Recap & Smart Investment Allocation Tips - newser.com
Aug Highlights: How Immunome Inc. stock benefits from tech adoptionMarket Activity Recap & Fast Moving Stock Trade Plans - Fundação Cultural do Pará
Immunome (NASDAQ:IMNM) Trading 8.3% HigherTime to Buy? - MarketBeat
Will Immunome Inc. stock outperform Nasdaq indexInsider Selling & Proven Capital Preservation Tips - Fundação Cultural do Pará
Can Immunome Inc. stock beat analyst upgradesEarnings Summary Report & Free High Accuracy Swing Entry Alerts - Fundação Cultural do Pará
Why Immunome Inc. stock is popular among millennialsLayoff News & AI Driven Stock Price Forecasts - Fundação Cultural do Pará
Can machine learning forecast Immunome Inc. recoveryJuly 2025 PostEarnings & High Yield Stock Recommendations - newser.com
Immunome’s Phase 1 Cancer Study: A Potential Game-Changer? - TipRanks
Chart overlay techniques for tracking Immunome Inc.Weekly Profit Report & Community Trade Idea Sharing - newser.com
How Immunome Inc. stock performs in rate cut cycles2025 Bull vs Bear & Smart Money Movement Tracker - newser.com
Immunome's (IMNM) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Takes $428,000 Position in Immunome, Inc. $IMNM - MarketBeat
Finanzdaten der Immunome Inc-Aktie (IMNM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):